U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
107311107311Amputee Residual Limb Volume FluctuationCompletedNo Results AvailableAmputationOther: Monitored for limb volumehttps://ClinicalTrials.gov/show/NCT01161238
107312107312Teen Asthma ProjectCompletedHas ResultsAsthmaBehavioral: Peer-assisted asthma self-management program|Behavioral: Adult-led asthma self-management programhttps://ClinicalTrials.gov/show/NCT01161225
107313107313REGULarity of Physical ActivitieS (REGUL'APS)CompletedNo Results AvailableOverweight|ObesityOther: Physical education sessions|Other: Physical education sessionshttps://ClinicalTrials.gov/show/NCT01161212
107314107314The Use of Leukapheresis to Support HIV Pathogenesis StudiesRecruitingNo Results AvailableHIVProcedure: Leukapheresishttps://ClinicalTrials.gov/show/NCT01161199
107315107315Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNo Results AvailablePancreatic Neoplasms|Pancreatic Cancer|AdenocarcinomaDrug: nab-paclitaxel, gemcitabine, capecitabinehttps://ClinicalTrials.gov/show/NCT01161186
107316107316An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (TEAM)CompletedNo Results AvailableNon-Squamous Non-Small Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT01161173
107317107317Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years OldCompletedNo Results AvailableInfluenzaBiological: GSK Biologicals' GSK2340274A (two different formulations)|Biological: GSK Biologicals' - GSK2340272Ahttps://ClinicalTrials.gov/show/NCT01161160
107318107318Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionCompletedNo Results AvailableHealthyDrug: Meloxicamhttps://ClinicalTrials.gov/show/NCT01161147
107319107319Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionCompletedNo Results AvailableHealthyDrug: Meloxicamhttps://ClinicalTrials.gov/show/NCT01161134
107320107320Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization LabRecruitingNo Results AvailableCoronary Artery DiseaseDrug: adenosine|Drug: regadenoson|Drug: Adenosinehttps://ClinicalTrials.gov/show/NCT01161121
107321107321Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental DisabilitiesCompletedNo Results AvailableEpilepsy|Insomnia|Developmental DisabilityDrug: Fast Release Melatonin (FR MLT)|Drug: Fast Release Placebo|Drug: Timed Release Melatonin (TR MLT)|Drug: Timed Release Placebohttps://ClinicalTrials.gov/show/NCT01161108
107322107322A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum PeriodRecruitingNo Results AvailableContraception|Postpartum PeriodDevice: LNG-IUShttps://ClinicalTrials.gov/show/NCT01161095
107323107323Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant AtorvastatinCompletedNo Results AvailableHypercholesterolemiaDrug: REGN727(SAR236553)https://ClinicalTrials.gov/show/NCT01161082
107324107324A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older VolunteersCompletedNo Results AvailableHealthyDrug: PF-03049423|Drug: PF-03049423|Drug: PF-03049423|Drug: PF-03049423|Drug: PF-03049423|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01161069
107325107325Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory PathwaysCompletedNo Results AvailableImmune System Diseaseshttps://ClinicalTrials.gov/show/NCT01161056
107326107326New Glucose Sensor PediatricCompletedNo Results AvailableType 1 Diabetes Mellitushttps://ClinicalTrials.gov/show/NCT01161043
107327107327Almonds and Diabetes ManagementCompletedNo Results AvailableType 2 DiabetesOther: almondshttps://ClinicalTrials.gov/show/NCT01161030
107328107328Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?Active, not recruitingNo Results AvailableMigraineDrug: Amitriptyline|Drug: Topiramatehttps://ClinicalTrials.gov/show/NCT01161017
107329107329Recovery Effect of Sugammadex Measured by Bispectral and Neurosense IndicesRecruitingNo Results AvailableAnesthesiaDrug: Sugammadex - Nacl 9/00|Drug: Nacl 9/00 - sugammadexhttps://ClinicalTrials.gov/show/NCT01161004
107330107330Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose MetabolismCompletedNo Results AvailableSchizophrenia|Diabetes|Insulin ResistanceProcedure: Glucose clamp technique|Drug: Amisulpride|Drug: Olanzapine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01160991
107331107331Donor Simvastatin Treatment in Organ TransplantationEnrolling by invitationNo Results AvailableHeart Failure|Respiratory Failure|Liver Failure|Kidney Failure|TransplantationDrug: Simvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01160978
107332107332Ropivacaine 0.75% Versus Levobupivacaine 0.5% for Conversion of Labour EpiduralWithdrawnNo Results AvailableCaesarean SectionDrug: 0.5% levobupivacaine|Drug: 0.75% Ropivacainehttps://ClinicalTrials.gov/show/NCT01160965
107333107333Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell TransplantationRecruitingNo Results AvailableHematological Diseases|Allogeneic Stem Cell TransplantationDrug: itraconazolehttps://ClinicalTrials.gov/show/NCT01160952
107334107334Assessment and Monitoring of Patients in Medium-term Heart Transplant Candidates Undergoing Low-intensity ExerciseCompletedNo Results AvailableHeart FailureOther: low intensity exercisehttps://ClinicalTrials.gov/show/NCT01160939
107335107335Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY TrialTerminatedNo Results AvailableRectal CancerDrug: AZD6244|Drug: Cediranib (AZD2171)https://ClinicalTrials.gov/show/NCT01160926
107336107336Optimal Site of Administration for Continuous Wound Infusion After Cesarean SectionCompletedNo Results AvailableCesarean SectionProcedure: Continuous wound infusion|Procedure: Continuous woundhttps://ClinicalTrials.gov/show/NCT01160913
107337107337FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization.Active, not recruitingNo Results AvailableMyocardial Infarction|Ischemia|Heart Failure|Necrosis|StentsProcedure: Coronary angioplasty all lesionshttps://ClinicalTrials.gov/show/NCT01160900
107338107338Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative StudyCompletedNo Results AvailableDiabetes Mellitus|Peripheral Neuropathy|Small Fibre Neuropathy|Autonomic Neuropathyhttps://ClinicalTrials.gov/show/NCT01160887
107339107339Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention Deficit Disorder With HyperactivityOther: Polysomnography|Other: Maintenance Wakefulness Test|Behavioral: Neuropsychological evaluation|Other: Driving test on a simulatorhttps://ClinicalTrials.gov/show/NCT01160874
107340107340A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic RhinitisCompletedNo Results AvailableAllergic RhinitisDrug: MEMP1972A|Drug: placebohttps://ClinicalTrials.gov/show/NCT01160861

* Görseller ve İçerik tekif hakkına sahip olabilir